Becton Dickinson & Co.
BDX
Market Cap$47.93B
Close$
Earnings Call Q2 2025
May 1, 2025 - AI Summary
Q2 Results Underperformance: BD reported a revenue growth of 6%, or 0.9% organic growth, which was below expectations. The underperformance was primarily due to challenges in the Life Sciences segment, driven by a reduction in research funding and a slower-than-anticipated recovery in blood culture testing within Diagnostics.
Revised Organic Growth Guidance: The company has adjusted its full-year organic growth forecast down to 3% - 3.5%, citing significant macroeconomic challenges, particularly in research funding policies and ongoing issues in their China market, including volume-based procurement impacts.
Strong Margin Performance: Despite the revenue challenges, BD was able to exceed its adjusted EPS expectations with growth of 5.7% to $3.35. The adjusted gross margin improved to 54.9%, up 190 basis points year-over-year, indicating effective cost management and productivity improvements through their BD Excellence initiative.
Exclusive for Stockcircle Pro members
Sign up
$615.00
250.7% upside
Current Fair Value
250.7% upsideUndervalued by 250.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $47.93 Billion |
|---|---|
| Enterprise Value | $65.80 Billion |
| Dividend Yield | $3.98 (2.38009807439302%) |
| Earnings per Share | $5.88 |
| Beta | 0.34 |
| Outstanding Shares | 288,411,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 32.19 |
|---|---|
| PEG | 11.11 |
| Price to Sales | 2.54 |
| Price to Book Ratio | 1.54 |
| Enterprise Value to Revenue | 3.26 |
| Enterprise Value to EBIT | 33.48 |
| Enterprise Value to Net Income | 38 |
| Total Debt to Enterprise | 0.28 |
| Debt to Equity | 0.34 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Becton, Dickinson And Co.
72,000 employees
CEO: Thomas Polen BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of hea...